| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 444,745 | 305,439 | 177,700 | | Cost of Revenue | 131,135 | 71,445 | 45,748 | | | Gross Profit | 313,610 | 233,994 | 131,952 | | | Operating Expenses | | Research Development | 76,680 | 51,587 | 39,882 | | Selling General and Administrative | 226,149 | 156,836 | 101,155 | | Non Recurring | 1,546 |
-
| (19) | | Others | 6,667 | 450 | 619 | | | | Total Operating Expenses | 311,042 |
-
| 141,637 | | | | Operating Income or Loss | 2,568 | 25,121 | (9,685) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,060) | 5,409 | 3,611 | | Earnings Before Interest And Taxes | 1,508 | 30,530 | (6,074) | | Interest Expense | 885 |
-
|
-
| | Income Before Tax | 623 | 30,530 | (6,074) | | Income Tax Expense | 9,131 | (2,038) | 1,124 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,508) | 32,568 | (7,198) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (8,508) | 32,568 | (7,198) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,508) | $32,568 | ($7,198) |
|
1.48% Nasdaq 
Income Statement
